Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis. (1st July 2020)

• Record Type: Journal Article
• Authors: Skroza, Nevena; Mambrin, Alessandra; Proietti, Ilaria; Balduzzi, Veronica; Bernardini, Nicoletta; Marchesiello, Anna; Michelini, Simone; Tolino, Ersilia; Volpe, Salvatore; Maddalena, Patrizia; Ciaramella, Antonella; Raimondi, Gianfranco; Potenza, Concetta
• Other Names: Romani Annalisa Guest Editor.
• Is Part Of: Cardiovascular therapeutics. Volume 2020(2020)
• Publication Date: 2020-07-01
• Subjects: Cardiovascular pharmacology -- Periodicals; Cardiovascular agents -- Periodicals; Cardiovascular system -- Diseases -- Chemotherapy -- Periodicals; Cardiovascular Agents -- Periodicals; Cardiovascular Diseases -- drug therapy -- Periodicals; Agents cardiovasculaires -- Périodiques; Appareil cardiovasculaire -- Maladies -- Chimiothérapie -- Périodiques; 616.1005
• DOI: 10.1155/2020/1321782
• Languages: English
• ISSNs: 1755-5914

Abstract

Abstract : Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with elevated prevalence of comorbidities, especially metabolic and cardiovascular diseases. We used a tool called Heart Rate Variability (HRV) in order to assess the correlation between HS and alterations of the sympathetic-vagal equilibrium in the autonomic cardiovascular regulation system. We found increased sympathetic activity, associated with a higher risk of cardiovascular disease. HS, according to our results, is an independent cardiovascular risk factor.